31 |
Methods of programming increased milk production and its relationship with sustainability of the dairy industryCarpenter, Abigail Joy January 1900 (has links)
Doctor of Philosophy / Department of Animal Sciences and Industry / Barry Bradford / High levels of milk production has been and will continue to be a priority for the global dairy industry. Non-steroidal antiinflammatory drugs administered to dairy cattle following calving can be an effective way of programming higher milk production for the entirety of lactation. When dairy cattle on a commercial dairy received either sodium salicylate or meloxicam following calving, they responded with increased whole-lactation milk production, which was driven by higher daily milk yields following the seventh week of lactation. When dairy cattle at a research dairy received sodium salicylate following calving, they did not show the same increase in milk production but feed intake, feeding behavior, and blood parameters were altered for an extended period of time. The response to treatment was largely dependent on the parity of the animal. In an effort to determine whether re-programming of the rumen environment could explain these findings, sodium salicylate was administered to batch cultures of rumen fluid, and as a result, fermentation was inhibited. When substrate was fermented in rumen fluid from heifers who had been dosed with sodium salicylate, fermentation was inhibited for an extended period of time following sodium salicylate administration. Beyond the use of compounds such as these, other factors can program lactation for higher milk production, including the gender of the calf. Analysis of lactation records from the US has indicated that cows produce more milk following the birth of a heifer calf compared to a bull. With further research, findings such as these can provide farmers with more tools for improving productivity and lead to the sustainability of the dairy industry as a whole.
|
32 |
Tenoxicam controla a dor sem apresentar efeito preemptivo ou interferir na movimentação ortodôntica de dentes caninos / Tenoxicam controls pain without present preemptive effect or interfere on canine teeth orthodontic movementArantes, Glacus de Miranda 22 June 2009 (has links)
O controle da dor na ortodontia é necessário, pois a movimentação dos elementos dentais por forças específicas causa uma reação inflamatória no periodonto e consequente sensação dolorosa. O controle do processo inflamatório pode alterar a movimentação ortodôntica pela diminuição da irrigação sanguínea do periodonto. Este trabalho prospectivo, duplo-cego randomizado, estudou o efeito do tenoxicam na analgesia preemptiva e na movimentação ortodôntica de caninos superiores. Foram avaliados 36 pacientes submetidos a retrações ortodônticas bilaterais de dentes caninos superiores. Cada lado foi tratado em 3 momentos distintos, totalizando 216 ativações de retração, realizadas altenando-se os lados. O paciente foi seu próprio controle. As retrações foram divididas em três grupos de 24 pacientes cada. No grupo A, foi realizada a retração administrando-se o tenoxicam via oral para controle da dor, quarenta e cinco minutos antes do procedimento e imediatamente após o mesmo houve a administração do placebo. No grupo B, o placebo foi administrado quarenta e cinco minutos antes do procedimento e o tenoxicam imediatamente após o término do mesmo, e no Grupo C os pacientes receberam o placebo tanto antes quanto depois da retração. Esses procedimentos se repetiram em intervalos de 15 dias, totalizando 90 dias de tratamento por paciente. Os pacientes puderam utilizar como resgate o analgésico dipirona sempre que fosse necessário. Questionários contendo a escala analógica visual (EAV), a descritiva de dor (EDD) e uma tabela para controle do consumo de analgésico resgate foram fornecidos após cada procedimento. As movimentações foram executadas pela técnica de Roth (arco reto) com forças padronizadas por um dinamômetro e molas de níquel titânio (NiTi). A quantidade de movimentação foi avaliada por meio de medidas lineares aferidas com um paquímetro. O tenoxicam não influenciou a movimentação dos dentes, uma vez que os resultados obtidos mostraram que a quantidade de movimentação não foi estatisticamente diferente entre os 3 grupos. Os pacientes que receberam o tenoxicam tiveram melhor controle da dor que os pacientes controle, não sendo evidenciado efeito preemptivo neste modelo de dor. Os resultados permitiram concluir que o tenoxicam não demonstrou influência na movimentação ortodôntica de retração de caninos, proporcionando um bom controle de dor ao longo das ativações / Pain control is need in orthodontics because the tooth movements caused by specific forces lead to an inflammatory reaction in the periodontium and a consequent painful sensation. Controlling the inflammatory process may change the orthodontic movement through diminishing the blood irrigation of the periodontium. This doubleblind randomized prospective study investigated the effect of preemptive analgesia using tenoxicam and its influence on upper canine orthodontic movement. Thirty-six patients who underwent bilateral orthodontic retraction of the upper canines were evaluated. Each side was treated on three different occasions, thus totaling 216 retraction activations, which were implemented with alternation between the sides. The patients were themselves the controls. The retractions were divided into three groups of 24 patients each. In group A, the retraction was implemented with tenoxicam administered orally to control the pain intensity, fourty five minutes before the procedure, placebo was then administered immediately after the procedure. In group B, placebo was administered 45 minutes before the procedure and tenoxicam immediately afterwards. In group C, placebo was administered both before and after the procedure. These procedures were repeated at 15-day intervals, thus totaling 90 days of treatment per patient. The patients were allowed to use dipyrone as rescue medication whenever necessary. Questionnaires containing a visual analog scale, a descriptive pain scale and a table for monitoring the rescue medication intake were supplied to the patients after each procedure. The movements were implemented using the Roth technique (straight arch), with forces standardized using a dynamometer and nickel-titanium springs. The amount of movement was evaluated by means of linear measurements using a pachymeter. The tenoxicam did not influence the teeth movement, since the obtained results shown that the amounts of movement did not differ statistically between the three groups. The patients medicated with tenoxicam achieved better pain control than did the patients in the control group, but no preemptive effect was shown in this pain model. The results allow to conclusion that the tenoxicam did not show any influence on the orthodontic movement of canine retraction and it provided good pain control over the course of the activations
|
33 |
Efeitos das drogas antiinflamatórias não-estereoidais sobre o epitélio bucal e a capacidade de cicatrização / Effects of non-steroidal anti-inflammatory drugs on oral epithelium and wound healing on skin of ratsNakao, Cristiano 29 August 2008 (has links)
Antiinflamatórios não-esteroidais (AINEs) são muito utilizados para o alívio da dor. Estudos indicam que 1 em 7 pacientes com doenças inflamatórias crônicas usam AINEs e que 1 em 5 pessoas usam AINEs para dores agudas. Os AINEs inibem a cicloxigenase (COX-1 e COX-2) ou seletivamente a COX-2, e apesar de sua excelente ação antiinflamatória e analgésica, muitos são os efeitos colaterais. Problemas gastrointestinais (GI) são a queixa mais comum para os AINEs convencionais, que também são associados a apoptose de diferentes tipos celulares. Os COX-2 seletivos apresentam menos problemas GI, mas seu uso tem sido questionado pelo risco de trombose e enfarto do miocárdio. Todos os AINEs parecem interferir no processo de cicatrização, embora os resultados dos estudos realizados apresentem-se conflitantes. Uma vez que os AINEs são utilizados por grande número de pessoas, o objetivo do nosso trabalho foi avaliar os efeitos dessa medicação sobre o tecido epitelial e durante o processo de cicatrização. Ratos Wistar foram tratados diariamente com AINEs convencional (diclofenaco, 3mg/Kg) ou um COX-2 seletivo (Celecoxibe, 1mg/Kg) por períodos de 7 e 14 dias. O controle foi feito com animais da mesma idade e peso não submetidos ao tratamento com AINEs. Após 7 dias, em todos os animais, controles e tratados, foram realizadas feridas cirúrgicas (4cm de diâmetro) no dorso depilado, sob anestesia com Tribromoetanol. Foram analisados, histológica e histometricamente, os epitélios da mucosa bucal, e a área de cicatrização (3 e 7 dias pós-cirurgia). Os resultados obtidos foram tabelados para avaliação estatística apropriada. No geral foi possível observar que todos os AINEs provocaram alterações com o seu uso agudo, no entanto para os inibidores seletivos da COX- 2 houve uma tendência à normalização com o uso crônico, não observada com o uso do AINE convencional. Na avaliação da cicatrização foi possível observar que os AINEs convencionais provocaram um pequeno atraso no processo de cicatrização, o que não foi observado com o uso de AINE seletivo para COX-2. Foi possível concluir que é necessário cautela em pacientes que fazem uso de AINEs, por provocarem alterações significativas no epitélio bucal, sendo os convencionais os que apresentam alterações mais significativas principalmente a longo prazo / Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for pain relief mostly in inflammatory chronic diseases. One in 7 patients with chronic inflammatory diseases uses NSAIDs, 1 in 5 uses NSAIDs for acute pain. NSAIDs may inhibit cyclooxygenase (COX-1 and COX-2) or COX-2 selectively, and despite their excellent anti-inflammatory and analgesic action, there are many side effects related. Gastrointestinal (GI) problems are the most commmon complaint for conventional NSAIDs, wich are also associated with different cell types apoptosis. The COX-2 selective NSAIDs have less GI problems, but may be associated to risks of cardiovascular events. All of NSAIDs seems to interfere with wound healing, although studies results may show conflicting results. Since NSAIDs are used by large numbers of people, the aim of this study was to evaluate the effects of this medication on the epithelial tissue and during wound healing process. Wistar rats were treated daily with conventional NSAIDs (diclofenac, 3mg/Kg) or selective COX-2 (celecoxib, 1mg/Kg) for a period of 7-14 days. The control group was animals of similar age and weight not treated with NSAIDs. After 7 days in all the animals, control and treated, were made surgical wounds (4cm in diameter) on the shaved back under anesthesia with Tribromoethanol. Oral mucosa and wound healing were histological and histometrically analyzed (3 and 7 days after surgery). The results received appropriated statistical evaluation. It was possible to observe that both NSAIDs lead to changes with acute use, but only selective COX-2 inhibitors tends to get back to normal parameters with long lasting use. Related to wound healing, it was possible to verify that conventional NSAIDs was associated to a slightly delay in wound healing process, which was not observed with selective COX-2 NSAIDs use. It was possible to conclude that caution is needed with the use of NSAIDs. They cause significant changes in oral epithelium and the convenional one causes most signifcant changes with long term use
|
34 |
Efeito do celecoxib sobre o desenvolvimento de doença periodontal induzida em ratos /Holzhausen, Marinella. January 2001 (has links)
Resumo: Os metabólitos do AA exercem um reconhecido papel na patogênese da doença periodontal. O objetivo deste trabalho foi avaliar o efeito do celecoxib, um inibidor seletivo da enzima cicloxigenase-2 (COX-2), sobre o desenvolvimento de doença periodontal induzida por ligadura em ratos. Após a colocação de ligadura de algodão ao redor dos primeiros molares inferiores direitos, 180 ratos Holtzman foram aleatoriamente subdivididos em 3 grupos experimentais com 60 animais cada, os quais receberam diariamente dose oral de celecoxib 10 mg ou 20 mg/ kg de peso corporal (grupos Ce1 e Ce2, respectivamente) ou, dose oral de 10ml/kg de NaCl a 0,9% (grupo Controle). Aos 3, 5, 10, 18 e 30 dias após o início do experimento, 12 animais de cada grupo experimental foram sacrificados. O tratamento com celecoxib, em ambas as concentrações, reduziu significantemente (p<0.05) a perda óssea alveolar radiográfica aos 5 dias e, diminuiu a intensidade da reabsorção óssea, observada histologicamente, aos 30 dias. Ainda, o celecoxib atrasou o início e, diminui a magnitude, do processo inflamatório agudo. Estes resultados demonstram que a inibição seletiva da COX-2 com o celecoxib, pode interferir com a resposta do tecido periodontal frente à presença de ligadura em ratos. / Abstract: Arachidonic acid metabolites have a recognized role in the pathogenesis of periodontal disease. The purpose of this study was to evaluate the effect of a selective cyclooxygenase-2 (COX-2) inhibitor, celecoxib, on the progression of periodontal disease in a ligature-induced periodontitis model in rats. After ligature placement in the mandibular right first molars, 180, 6-week-old Holtzman rats were ramdomly assigned to one of the following groups of treatment that consisted in a daily oral dose of 10mg/kg body weight of celecoxib (Ce1), 20mg/kg body weight of celecoxib (Ce2) or 10ml/kg of 0,9%NaCl (Control). At 3, 5, 10, 18 and 30 days later, 12 animals of each group were sacrificed. Treatment with celecoxib significantly (p < 0.05) decreased the radiographic bone loss at 5 days of experiment and, decreased the bone loss activity, histologically observed at 30 days. In addition, celecoxib was shown to delay the onset and to suppress the magnitude of the acute inflammatory process. These results show that selective cyclooxygenase-2 (COX-2) inhibition with celecoxib, can interfer with the periodontal tissue response to ligature placement in rats. / Orientador: Luís Carlos Spolidorio / Coorientador: Elcio Marcantonio Junior / Banca: Joni Augusto Cirelli / Banca: Maria Angela Naval Machado / Mestre
|
35 |
Efeitos das drogas antiinflamatórias não-estereoidais sobre o epitélio bucal e a capacidade de cicatrização / Effects of non-steroidal anti-inflammatory drugs on oral epithelium and wound healing on skin of ratsCristiano Nakao 29 August 2008 (has links)
Antiinflamatórios não-esteroidais (AINEs) são muito utilizados para o alívio da dor. Estudos indicam que 1 em 7 pacientes com doenças inflamatórias crônicas usam AINEs e que 1 em 5 pessoas usam AINEs para dores agudas. Os AINEs inibem a cicloxigenase (COX-1 e COX-2) ou seletivamente a COX-2, e apesar de sua excelente ação antiinflamatória e analgésica, muitos são os efeitos colaterais. Problemas gastrointestinais (GI) são a queixa mais comum para os AINEs convencionais, que também são associados a apoptose de diferentes tipos celulares. Os COX-2 seletivos apresentam menos problemas GI, mas seu uso tem sido questionado pelo risco de trombose e enfarto do miocárdio. Todos os AINEs parecem interferir no processo de cicatrização, embora os resultados dos estudos realizados apresentem-se conflitantes. Uma vez que os AINEs são utilizados por grande número de pessoas, o objetivo do nosso trabalho foi avaliar os efeitos dessa medicação sobre o tecido epitelial e durante o processo de cicatrização. Ratos Wistar foram tratados diariamente com AINEs convencional (diclofenaco, 3mg/Kg) ou um COX-2 seletivo (Celecoxibe, 1mg/Kg) por períodos de 7 e 14 dias. O controle foi feito com animais da mesma idade e peso não submetidos ao tratamento com AINEs. Após 7 dias, em todos os animais, controles e tratados, foram realizadas feridas cirúrgicas (4cm de diâmetro) no dorso depilado, sob anestesia com Tribromoetanol. Foram analisados, histológica e histometricamente, os epitélios da mucosa bucal, e a área de cicatrização (3 e 7 dias pós-cirurgia). Os resultados obtidos foram tabelados para avaliação estatística apropriada. No geral foi possível observar que todos os AINEs provocaram alterações com o seu uso agudo, no entanto para os inibidores seletivos da COX- 2 houve uma tendência à normalização com o uso crônico, não observada com o uso do AINE convencional. Na avaliação da cicatrização foi possível observar que os AINEs convencionais provocaram um pequeno atraso no processo de cicatrização, o que não foi observado com o uso de AINE seletivo para COX-2. Foi possível concluir que é necessário cautela em pacientes que fazem uso de AINEs, por provocarem alterações significativas no epitélio bucal, sendo os convencionais os que apresentam alterações mais significativas principalmente a longo prazo / Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for pain relief mostly in inflammatory chronic diseases. One in 7 patients with chronic inflammatory diseases uses NSAIDs, 1 in 5 uses NSAIDs for acute pain. NSAIDs may inhibit cyclooxygenase (COX-1 and COX-2) or COX-2 selectively, and despite their excellent anti-inflammatory and analgesic action, there are many side effects related. Gastrointestinal (GI) problems are the most commmon complaint for conventional NSAIDs, wich are also associated with different cell types apoptosis. The COX-2 selective NSAIDs have less GI problems, but may be associated to risks of cardiovascular events. All of NSAIDs seems to interfere with wound healing, although studies results may show conflicting results. Since NSAIDs are used by large numbers of people, the aim of this study was to evaluate the effects of this medication on the epithelial tissue and during wound healing process. Wistar rats were treated daily with conventional NSAIDs (diclofenac, 3mg/Kg) or selective COX-2 (celecoxib, 1mg/Kg) for a period of 7-14 days. The control group was animals of similar age and weight not treated with NSAIDs. After 7 days in all the animals, control and treated, were made surgical wounds (4cm in diameter) on the shaved back under anesthesia with Tribromoethanol. Oral mucosa and wound healing were histological and histometrically analyzed (3 and 7 days after surgery). The results received appropriated statistical evaluation. It was possible to observe that both NSAIDs lead to changes with acute use, but only selective COX-2 inhibitors tends to get back to normal parameters with long lasting use. Related to wound healing, it was possible to verify that conventional NSAIDs was associated to a slightly delay in wound healing process, which was not observed with selective COX-2 NSAIDs use. It was possible to conclude that caution is needed with the use of NSAIDs. They cause significant changes in oral epithelium and the convenional one causes most signifcant changes with long term use
|
36 |
The effectiveness of rofecoxib on post-endodontic painMoore, Stephen H., January 2002 (has links)
Thesis (M.S.)--West Virginia University, 2002. / Title from document title page. Document formatted into pages; contains viii, 51 p. : ill. Includes abstract. Includes bibliographical references (p. 39-42).
|
37 |
New potential targets in medulloblastoma therapy studies on cellular mechanisms and mediators /Baryawno, Ninib, January 2010 (has links)
Diss. (sammanfattning) Stockholm : Karolinska institutet, 2010.
|
38 |
The role of curcumin in human dendritic cell maturation and function /Shirley, Shawna A. January 2008 (has links)
Dissertation (Ph.D.)--University of South Florida, 2008. / Includes vita. Includes bibliographical references. Also available online.
|
39 |
THE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS-MYOCARDIAL INFARCTION ASSOCIATION: AN INVESTIGATION OF KENTUCKY MEDICAID PRESCRIPTION CLAIMSGordon, Leonard A. 01 January 2015 (has links)
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used medications globally. There are generally two types: selective (COX-2) and traditional NSAIDs (COX-1). They are primarily used for the treatment of pain. They gained attention after a study about their basic mechanisms highlighted their toxicity.
Several studies have reported an association between NSAIDs and risk of myocardial infarction (MI). However, the direction of the relationship is not conclusive. Further studies are needed to ascertain the direction of this relationship and evaluate the present situation with available drugs. Due to the seriousness of cardiovascular diseases as one of the leading cause of death, continuous monitoring of the NSAIDs-MI association is needed.
The purpose of this dissertation was to investigate the association between NSAIDs and MI in a younger (30-64 years) Kentucky Medicaid population with a 12 year window of data. The three specific aims were: (1) to understand the characteristics of the Kentucky Medicaid population with respect to NSAID use: (2) to evaluate the NSAID-MI relationship with a 12 year follow-up in a young heavily-burdened population for cardiovascular diseases: and (3) to investigate the MI risk of meloxicam, celecoxib and naproxen compared to no exposure.
A retrospective study was conducted employing data from January 1st 2000 and December 31st 2012. The data comprised demographic, prescription and medical files. Within this cohort, a nested case control study was conducted. Cases of MI were matched to four controls on race and gender.
The results suggested that exposure to COX 2 presented an increased adjusted risk for MI (1.138(0.983, 1.318)). However, this risk was significantly increased for COX-2 only users compared to COX-1 only users (1.221 (1.03, 1.485)) and 30-40 year olds (1.600 (1.082, 2.367)).
Meloxicam, celecoxib and naproxen compared to no exposure showed meloxicam presented a non-significant different risk for MI (1.26 (0.98, 1.63)) and celecoxib presented a significantly increased risk for MI (1.52 (1.26, 1.82)).
This study considered pattern of use in determining continuous usage by looking at both continuous and sporadic users of NSAIDs and also considered patient switching patterns between classes of NSAIDs.
|
40 |
Σύνθεση και in vivo αντιλευχαιμική δράση των 5α-7-κετο τροποποιημένων και μη στεροειδών εστέρων της χλωραμβουκίλης και του ενεργού μεταβολίτη αυτήςΠαπακωνσταντίνου, Ιωάννα 16 January 2009 (has links)
Εστιάζοντας στα αποτελέσματα προσφάτων μελετών, οι οποίες είχαν ως θέμα τη διερεύνηση της σχέσης μεταξύ της χημικής δομής και της αντιλευχαιμικής δράσης, προκύπτει ότι το στεροειδικό τμήμα των ενώσεων που περιέχουν αλκυλιωτικούς παράγοντες, δεν αποτελεί μόνο τον βιολογικό φορέα των αλκυλιωτικών παραγόντων. Ο σχεδιασμός και η μελέτη παρόμοιων ενώσεων, οι οποίες έφεραν στη θέση 7 του στεροειδικού σκελετού μία αλλυλική κετόνη, παρουσίασαν μία σημαντικά αυξημένη αντιλευχαιμική δραστικότητα συγκριτικά με παράγωγα που περιείχαν στο μόριό τους έναν απλό στεροειδικό σκελετό. Προκειμένου να διερευνηθεί κατά πόσο η βελτίωση της αντιλευχαιμικής οφειλόταν στην εισαγωγή της 7-κετόνης ή του Δ5-7-κετο στεροειδικού συστήματος, αναγάγαμε το διπλό δεσμό στη θέση 5 του στεροειδούς. Τα 5α-7-κετο στεροειδικά παράγωγα που προέκυψαν κατά την αναγωγή του διπλού δεσμού χρησιμοποιήθηκαν αρχικά για τη σύνθεση των στεροειδικών εστέρων της χλωραμβουκίλης και του φαινυλοξικού οξέος και ακολούθως μελετήθηκε η in vivo αντιλευχαιμική τους δράση έναντι της λευχαιμίας Ρ388.
Τέλος, η αναγωγή του διπλού δεσμού αποδείχθηκε να έχει αρνητική επίδραση στην αντιλευχαιμική δράση, αφού η συγκριτική μελέτη με τα πρωτότυπα μόρια έδειξε πως οι πολύ δραστικοί Δ5-7-κετο στεροειδικοί εστέρες με την αναγωγή του διπλού δεσμού μετατράπηκαν σε ενώσεις με αμελητέα αντιλευχαιμική δράση. / Recent structure-antileukemic activity studies showed that the steroidal part of complex molecules containing DNA alkylators does not play only the role of the “biological carrier”. New such compounds designed to possess an allylic 7-ketone showed enhanced antileukemic potency compared with derivatives with a simple steroidal skeleton. In order to investigate whether the enhancement of the antileukemic potency is attributed to the introduction of the 7-ketone or to the Δ5-7-keto conjugated steroidal system we decided to reduce the Δ5 double bond. The 5α-7-keto-steroidal skeletons synthesized were tethered to chlorambucil and phenyl acetic acid’s nitrogen mustard and studied against leukemia P338 in vivo. The reduction of the double bond had a negative impact on the antileukemic potency since the comparative study of the novel derivatives showed that a series of very potent Δ5-7-keto-steroidal esters were converted by this modification to compounds with marginally accepted activity.
|
Page generated in 0.0614 seconds